Abstract: Sterol derivatives with structural formula I or II are disclosed, wherein R is defined as the description of the invention. Their synthesizing methods and anti-tumor use are also disclosed. Especially, the compound of formula I, in which R is O (i.e. the compound CL 168-6), has the anti-tumor therapeutic index of 49.3. The compound can be used to prepare a medicine for prevention or treatment of immunological diseases and cancers such as liver cancer and lung cancer.

Abstract: An advice of charging (AoC) method, system, and mobile terminal thereof are provided. The method includes receiving AoC information sent by a service charging server, and then displaying the AoC information. The mobile terminal includes a receiving module adapted to receive AoC information sent by a service charging server, and a display module adapted to display the received AoC information. The system includes a terminal, a service charging server, a service gateway, and a charging engine. The present invention is applicable to pre-consumption prompt, post-consumption notification, and prompts for data services such as browsing, streaming media, and mail.

Abstract: The invention relates to the cDNA and deduced amino acid sequence of the Coactivator Associated arginine (R) Methyltransferase protein, CARM1. A method is described for the use CARM1 to regulate gene expression in vivo. CARM1 has also been used to methylate arginine residues of histones, synthetic peptides, and other proteins. A method to use CARM1 to screen for drugs that inhibit its methyltransferase activity is also described, as is a method to screen for drugs that modulate CARM1's interactions with other proteins.

Abstract: Sterol derivatives with structural formula I or II are disclosed, wherein R is defined as the description of the invention. Their synthesizing methods and anti-tumor use are also disclosed. Especially, the compound of formula I, in which R is O (i.e. the compound CL 168-6), has the anti-tumor therapeutic index of 49.3. The compound can be used to prepare a medicine for prevention or treatment of immunological diseases and cancers such as liver cancer and lung cancer.

Abstract: The invention relates to the cDNA and deduced amino acid sequence of the Coactivator Associated arginine (R) Methyltransferase protein, CARM1. A method is described for the use CARM1 to regulate gene expression in vivo. CARM1 has also been used to methylate arginine residues of histones, synthetic peptides, and other proteins. A method to use CARM1 to screen for drugs that inhibit its methyltransferase activity is also described, as is a method to screen for drugs that modulate CARM1's interactions with other proteins.

Abstract: The invention relates to the cDNA and deduced amino acid sequence of the Coactivator Associated arginine (R) Methyltransferase protein, CARM1. A method is described for the use CARM1 to regulate gene expression in vivo. CARM1 has also been used to methylate arginine residues of histones, synthetic peptides, and other proteins. A method to use CARM1 to screen for drugs that inhibit its methyltransferase activity is also described, as is a method to screen for drugs that modulate CARM1's interactions with other proteins.

Abstract: A message processing method, device, and system are provided in the embodiments of the present invention. The method comprises: receiving service messages and identifying the protocol type of the service messages; performing protocol adaptation according to the protocol type; and reconstructing the content of the service messages after protocol adaptation according to the corresponding content reconstructing policies and sending the service messages after content reconstructing. The present invention implements information embedment into the content over different protocols without proxy server settings.

Abstract: The present invention discloses a method for transferring licenses, a device for issuing licenses, and a communication system, and relates to the Digital Rights Management (DRM) technology. The method includes: the first issuing device receives a request of transferring a license issued by the second issuing device; the first issuing device transfers the license after determining that a relationship is set up with the second issuing device. The license issuing device includes: a receiving module, a setup module, a determining module, and a sending module. The communication system includes: a first issuing device, a second issuing device, and a device requesting to transfer a license. Through the present invention, an issuing device may transfer the licenses issued by other issuing devices, thus improving the flexibility of transferring the licenses.

Abstract: An advice of charging (AoC) method, system, and mobile terminal thereof are provided. The method includes receiving AoC information sent by a service charging server, and then displaying the AoC information. The mobile terminal includes a receiving module adapted to receive AoC information sent by a service charging server, and a display module adapted to display the received AoC information. The system includes a terminal, a service charging server, a service gateway, and a charging engine. The present invention is applicable to pre-consumption prompt, post-consumption notification, and prompts for data services such as browsing, streaming media, and mail.

Abstract: A method for exporting permission is provided to solves the problem that the permission can not be exported multiple times among several DRM systems in the prior art; the method includes that: determining that a license is permitted to be exported to a system that a target device belongs to; determining whether an export permission in the license is permitted to be exported; and exporting the export permission in the license to the target device if the export permission in the license is permitted to be exported, which enables the target device to export the license to another device. A terminal apparatus, a server and a communication network are also disclosed.

Abstract: The invention relates to the cDNA and deduced amino acid sequence of the Coactivator Associated arginine (R) Methyltransferase protein, CARM1. A method is described for the use CARM1 to regulate gene expression in vivo. CARM1 has also been used to methylate arginine residues of histones, synthetic peptides, and other proteins. A method to use CARM1 to screen for drugs that inhibit its methyltransferase activity is also described, as is a method to screen for drugs that modulate CARM1's interactions with other proteins.

Abstract: The invention relates to the cDNA and deduced amino acid sequence of the Coactivator Associated arginine (R) Methyltransferase protein, CARM1. A method is described for the use CARM1 to regulate gene expression in vivo. CARM1 has also been used to methylate arginine residues of histones, synthetic peptides, and other proteins. A method to use CARM1 to screen for drugs that inhibit its methyltransferase activity is also described, as is a method to screen for drugs that modulate CARM1's interactions with other proteins.

Abstract: The invention relates to the cDNA and deduced amino acid sequence of the Coactivator Associated arginine (R) Methyltransferase protein, CARM1. A method is described for the use CARM1 to regulate gene expression in vivo. CARM1 has also been used to methylate arginine residues of histones, synthetic peptides, and other proteins. A method to use CARM1 to screen for drugs that inhibit its methyltransferase activity is also described, as is a method to screen for drugs that modulate CARM1's interactions with other proteins.

Abstract: The invention relates to the cDNA and deduced amino acid sequence of the Coactivator Associated arginine (R) Methyltransferase protein, CARM1. A method is described for the use CARM1 to regulate gene expression in vivo. CARM1 has also been used to methylate arginine residues of histones, synthetic peptides, and other proteins. A method to use CARM1 to screen for drugs that inhibit its methyltransferase activity is also described, as is a method to screen for drugs that modulate CARM1's interactions with other proteins.